BMP Sunstone Corporation Earnings Conference Call (Q4 2007)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Mar 17 Calls Today's Calls

Call Details BMP Sunstone Corporation Earnings Conference Call (Q4 2007) Mon, Mar 17, 2008, 8:30 am Eastern Listen to the archived event audio About BMP Sunstone Corporation (NasdaqGM:BJGP) BMP Sunstone Corporation operates as a pharmaceutical and over-the-counter, or OTC, manufacturing, marketing, and distribution company in China. It offers various marketing and promotional services, including pre-market entry analysis; clinical trial management; product registration; market research; pharmaceutical marketing to physicians, hospitals, and other healthcare providers; OTC marketing to retail pharmacies; and pharmaceutical distribution. The company also provides distribution services for various products, including western medicines, traditional Chinese medicines, bio-chemical medicines, and medical applications. BMP Sunstone’s products include Propess for the treatment of cervical ripening; Anpo for pre-term labor management; and Galake for cancer, trauma, and surgical pains. The company’s developing products include Ferriprox for iron overload; Flashtab Ondansetron for nausea and vomiting; Clindesse for bacterial vaginosis; Enablex for overactive bladder; Misopess for cervical ripening and labor induction; Fentora for pain management; Nuvigil for excessive sleepiness; and Myocet for breast cancer. Its OTC products consist of Hao Wawa pediatric granules, chewables, and syrups; Kang Fu Te line of gynecology suppositories; and Nemei line of women’s health products. The company was formerly known as Beijing Med-Pharm Corporation and changed its name to BMP Sunstone Corporation in February 2008. BMP Sunstone is based in Plymouth Meeting, Pennsylvania. More Info: Quote | Profile | Reports | Research | Insider | Financials